Operator

Thank you for standing by. My name is Roselle, and I will be your operator today. At this time, I would like to welcome everyone to the Palvella Therapeutics First Quarter 2026 Financial Results Conference Call. [Operator Instructions]

I will now turn the conference call over to Bohan Wei. Please go ahead.

Bohan Wei
Vice President of Corporate Development & New Product Planning

Thank you, operator. Good morning, and thank you for joining the Palvella Therapeutics Q1 2026 Financial Results and Corporate Update Call. As a reminder, our press release detailing today's announcements can be found in the Investors section of our website at www.palvellatx.com.

On today's call, you will first hear from Wes Kaupinen, our Founder and Chief Executive Officer; followed by Dr. David Osborne, our Chief Innovation Officer; Dr. Jeff Martini, our Chief Scientific Officer; and Matt Korenberg, our Chief Financial Officer.

Before we begin, please note that today's remarks may include forward-looking statements regarding our development programs, regulatory strategy, commercial planning and financial outlook. These